← All trials
NCT06858254
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2025
- Primary completion
- Apr 30, 2028
- Completion date
- Apr 30, 2028
- First posted
- Mar 5, 2025
- Last posted
- Mar 5, 2025
- Enrollment
- 60
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Apeiron BiologicsLead sponsor
- University of Colorado, BoulderCollaborator
- Apeiron BiologicsOfficial
- Apeiron BiologicsSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.